2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow ANCA-Associated Vasculitis: new trials by email Literature Review of ANCA-Associated Vasculitis trials Research Report on ANCA-Associated Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis Avacopan, Prednisone, Cyclophosphamide - ANCA-Associated Vasculitis | Phase 3 | Completed | Amgen | 331 | 2017-03-15 | 2025-03-24 |
| Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) Abatacept, placebo - Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis | Phase 3 | Completed | University of South Florida | 65 | 2015-04-25 | 2024-07-29 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Vasculitis (2) · Granulomatosis with Polyangiitis (1) · Lung Diseases (1) · Respiratory Tract Diseases (1) · Systemic Vasculitis (1) · Vascular Diseases (1)
Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Lung Diseases, Interstitial (1) · Systemic Vasculitis (1) · Vascular Diseases (1)
Abatacept (1) · Azathioprine (1) · Cyclophosphamide (1) · Prednisone (1) · Rituximab (1) · avacopan (1)
Amgen (1) · University of South Florida (1)
Canada (2) · Germany (2) · Ireland (2) · United Kingdom (2) · United States (2) · Australia (1) · Austria (1) · Belgium (1) · Czechia (1) · Denmark (1) · France (1) · Hungary (1) · Italy (1) · Japan (1) · Netherlands (1)
Carol A Langford, MD, MHS (1) · Jeffrey P Krischer, PhD (1) · Peter A Merkel, MD, MPH (1)
PMID 32088663, PMID 33367837, PMID 33596356, PMID 35167187, PMID 37979959, PMID 41052893
U54AR057319 (1)